Transgenic Group Inc. (TYO:2342)
Japan · Delayed Price · Currency is JPY 221.00
+7.00 (3.27%)
Aug 6, 2026, 3:12 PM JST
Transgenic Group Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | -207 | -675 | 43 | -331 | 2,767 |
Depreciation & Amortization | 155 | 241 | 149 | 182 | 227 |
Loss (Gain) From Sale of Assets | 47 | 227 | 3 | 205 | 672 |
Loss (Gain) From Sale of Investments | -137 | 10 | - | 12 | -1,342 |
Other Operating Activities | -50 | 39 | 81 | -457 | -167 |
Change in Accounts Receivable | 50 | 211 | -259 | -115 | 123 |
Change in Inventory | -250 | 12 | 10 | -467 | -353 |
Change in Accounts Payable | 206 | -117 | -173 | -430 | -87 |
Change in Other Net Operating Assets | 211 | 146 | -246 | -29 | -51 |
Operating Cash Flow | 25 | 94 | -392 | -1,430 | 1,789 |
Operating Cash Flow Growth | -73.40% | - | - | - | 46.40% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -68 | -175 | -264 | -306 | -532 |
Sale of Property, Plant & Equipment | - | 1 | 7 | 34 | - |
Cash Acquisitions | - | -80 | - | -693 | -185 |
Divestitures | - | - | - | -35 | 1,438 |
Investment in Securities | 131 | 5 | -12 | 200 | - |
Other Investing Activities | -13 | -38 | -11 | 490 | 259 |
Investing Cash Flow | 50 | -287 | -280 | -216 | 981 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Issued | - | 232 | 278 | - | - |
Long-Term Debt Issued | 390 | 600 | 210 | 1,240 | 220 |
Total Debt Issued | 390 | 832 | 488 | 1,240 | 220 |
Short-Term Debt Repaid | -115 | - | - | -220 | -410 |
Long-Term Debt Repaid | -761 | -480 | -634 | -401 | -550 |
Total Debt Repaid | -876 | -480 | -634 | -621 | -960 |
Net Debt Issued (Repaid) | -486 | 352 | -146 | 619 | -740 |
Repurchase of Common Stock | - | - | -78 | - | -298 |
Common Dividends Paid | - | -49 | -83 | -100 | -52 |
Other Financing Activities | -32 | -38 | -35 | -35 | -93 |
Financing Cash Flow | -518 | 265 | -342 | 484 | -1,183 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Foreign Exchange Rate Adjustments | - | 4 | 22 | 1 | - |
Miscellaneous Cash Flow Adjustments | 2 | -1 | -1 | 2 | 1 |
Net Cash Flow | -441 | 75 | -993 | -1,159 | 1,588 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -43 | -81 | -656 | -1,736 | 1,257 |
Free Cash Flow Growth | - | - | - | - | 16.71% |
Free Cash Flow Margin | -0.33% | -0.62% | -5.01% | -15.19% | 9.99% |
Free Cash Flow Per Share | -2.58 | -4.87 | -39.04 | -103.06 | 73.23 |
Levered Free Cash Flow | 372.13 | 360.5 | -607.63 | -1,026 | 639.38 |
Unlevered Free Cash Flow | 400.25 | 383.63 | -578.25 | -1,009 | 653.13 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 45 | 36 | 47 | 28 | 22 |
Cash Income Tax Paid | 49 | -36 | -81 | 456 | 168 |
Change in Working Capital | 217 | 252 | -668 | -1,041 | -368 |